SII countersues volunteer who alleged side effects from Covishield vaccine for Rs 100 cr

After a 40-year-old volunteer sought Rs 5 crore as dams from Serum Institute of India (SII) alleging "severe neurological and psychological symptoms" from ir potential COVID-19 vaccine, pharmaceutical company issued an official statement, disregarding claims.

SII categorically stated that  volunteer’s medical condition h correlation with vaccine trials that he underwent ding that he h alrey been me aware of this information by a medical team. Countersuing 40-year-old volunteer for Rs 100 crores, SII snubbed man's claims calling m 'malicious' and riddled with 'pecuniary motives.'

Earlier in day, a Chennai-based businessman claimed that he suffered from severe neurological and psychological symptoms after being ministered with a dose of Oxford's COVID-19 vaccine candidate - Covishield.

40-year-old trial candidate has sent a legal tice to Drugs Controller General of India (DCGI), ICMR, Central Drugs Standard Control Organisation, CEO of AstraZeneca and Vice-Chancellor of Sri Ramachandra Higher Education and Research. 

volunteer has also sought Rs 5 crore compensation and has demanded testing, manufacturing, and distribution of vaccine candidate be stopped immediately. 

Re: PM Modi Monitors Progress Of 'COVAXIN' In Hyderab's Bharat Biotech; Hails Efforts

Re: Man Alleges Neurological Illness After Receiving COVID-19 Vaccine Shot, Sends Legal tice

Serum Institute of India's full statement

Serum Institute of India is sympatic with volunteer’s medical condition, re's absolutely correlation with vaccine trial & his medical condition. He's falsely laying blame for his medical problems on trial.

claim is malicious because volunteer was specifically informed by medical team that complications he suffered were independent of vaccine trial he underwent. In spite of specifically being me aware of same, he still chose to go public & malign reputation of company. 

It is evident that intention behind spreing of such malicious information is an oblique pecuniary motive. We will seek dams in excess of Rs 100 crores for same and will defend such malicious claims.

Re: Serum Institute To Seek Emergency Authorization Of Covishield From DCGI In Next 2 Weeks

Re: CSIR To Wait For Peer-review On Efficacy Of Oxford's Covid Vaccine; 'but Very Encouraging'